Position in AUPH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$336,515
-$8,064 QoQ
Shares Held
19,830
-14.7% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#155
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. AUPH ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in AUPH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $336,515 | 19,830 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $344,579 | 23,251 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $440,873 | 27,641 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $271,852 | 24,602 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $247,315 | 29,199 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $283,458 | 35,256 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $400,400 | 44,588 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $247,878 | 33,817 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $153,981 | 26,967 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $172,664 | 34,464 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $284,003 | 31,591 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $209,533 | 26,967 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $260,072 | 26,867 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $281,376 | 25,673 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $125,340 | 29,014 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $200,964 | 26,724 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $262,345 | 26,104 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $181,490 | 14,660 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $417,629 | 18,261 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $607,003 | 27,429 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $298,429 | 23,027 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $228,964 | 17,633 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $270,141 | 19,533 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $299,681 | 20,345 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $292,467 | 17,998 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $214,211 | 14,763 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||